GRM1 and Alzheimer disease: Furthermore, recent findings demonstrated that blocking type 2A protein phosphatase (a key enzyme downstream of mGluR1 signaling) attenuated the microglial phagocytosis of glutamatergic synapses and cognitive deficiency in the rat model of AD [176].